A pilot study of three potential vaccines for leprosy in Bombay
Int. j. lepr. other mycobact. dis
; 57(1): 33-37, Mar. 1989. tab
Artigo
em Inglês
| Sec. Est. Saúde SP, HANSEN, Hanseníase, SESSP-ILSLACERVO, Sec. Est. Saúde SP
| ID: biblio-1226407
Biblioteca responsável:
BR191.1
Localização: [{"text": "Br191.1"}]
ABSTRACT
Three vaccines, BCG Glaxo alone (vaccine A), BCG Glaxo plus 10(7) killed Mycobacterium vaccae (vaccine B), and BCG Glaxo plus 10(7) killed M. leprae (vaccine C), were given to groups of selected children. The effects of these vaccines on subsequent quadruple skin testing 1-3 years after vaccination were compared. All three vaccines equally and significantly (p less than 0.00001) increased positivity to tuberculin, but only vaccine B was found to significantly enhance development of skin-test positivity to leprosin A (p less than 0.002). The data support the evidence previously obtained in rural Iran that the combination of BCG with killed M. vaccae is likely to be a better vaccine for leprosy than is BCG alone
Texto completo:
Disponível
Coleções:
Bases de dados nacionais
/
Brasil
Contexto em Saúde:
Doenças Negligenciadas
Problema de saúde:
Hanseníase
/
Doenças Negligenciadas
Base de dados:
HANSEN
/
Hanseníase
/
Sec. Est. Saúde SP
/
SESSP-ILSLACERVO
Assunto principal:
Hanseníase
/
Mycobacterium leprae
Limite:
Adolescente
/
Criança, pré-escolar
/
Humanos
Idioma:
Inglês
Revista:
Int. j. lepr. other mycobact. dis
Ano de publicação:
1989
Tipo de documento:
Artigo
Instituição/País de afiliação:
The Bombay Leprosy Project/IN
/
University College and Middlesex School/GB
